Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
During 1985–1990 the U.S. National Cancer Institute (NCI) phased out its murine leukemia P388 anticancer drug screening program and developed as the replacement a new in vitro primary screen based upon a diverse panel of human tumor cell lines. For each substance tested, the screen generates a remarkably reproducible and characteristic profile of differential in vitro cellular sensitivity, or lack thereof, across the 60 different cell lines comprising the panel. Several investigational approaches to display, analysis, and interpretation of such profiles and databases, derived from the testing of tens of thousands of substances during the past 4–5 years since the NCI screen became fully operational, have been explored. A variety of useful, practical applications of the in vitro screen have become apparent. As these applications continue to evolve, they are proving to be complementary to diverse other anticancer screening and drug discovery strategies being developed or pursued elsewhere. Reviewed herein are some practical considerations and selected specific examples, particularly illustrating research applications of the NCI screen that may be more broadly applicable to the search for new anticancer drug development leads with novel profiles of antitumor activity and/or mechanisms of action. © 1995 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in December 1992, MDA‐MB‐435 was added to the NCI‐60 cell line panel for use in anticancer drug screening, where it was initially described as a “breast” cancer cell line.17”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [17]
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Self-citationMonks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,289
Self-citationA Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Soule, H. D., Vazquez, J., Long, A., Albert, S., & Brennan, M. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1409 · Cited by 2,449
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,121
Breast Tumor Cell Lines From Pleural Effusions2
Cailleau, R., Young, R., Olivé, M., & Reeves, W. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.661 · Cited by 1,015
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 967
Self-citationRubinstein, L. V., Shoemaker, R. H., Paull, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1113 · Cited by 927
Self-citationIsolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
Establishment and characterization of a cell line of human breast carcinoma origin
Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., & Brenner, H. J. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90139-7 · Cited by 650
Research works printed but not linked: 6
- Acton EM, 1992, Anticancer specificity of some ellipticinium salts against human brain tumors in vitro, Proc Am Assoc Cancer Res, 33, 488
- Boyd MR, 1986, Accomplishments in Oncology, Vol 1, Cancer Therapy: Where Do We Go From Here?, 68
- Boyd MR, 1989, Cancer: Principles and Practice of Oncology Updates, 1
- Buolamwini JK, 1994, Searching for new molecular targets for therapy of cancer and AIDS: Characterization by 2D protein gel electrophoresis, Proc Am Assoc Cancer Res, 35, 613
- Grever MR, 1994, Status of in vivo evaluations in the NCI anticancer drug discovery program, Proc Am Assoc Cancer Res, 35, 369
- Stinson SF, 1992, Morphologic and immunocytochemical characteristics of human tumor cell lines for use in an anticancer drug screen, Anticancer Res, 12, 1035
Cited by
Items 401–500 of 1,000
Novel analogs of d-e-MAPP and B13. Part 1: Synthesis and evaluation as potential anticancer agents
Szulc, Z. M., Mayroo, N., Bai, A., Bielawski, J., Liu, X., Norris, J. S., Hannun, Y. A., & Bielawska, A. E. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.033 · Cited by 47
Farag, A. M., Mayhoub, A. S., Eldebss, T. M. A., Amr, A. E. E., Ali, K. A. K., Abdel‐Hafez, N. A., & Abdulla, M. M. (2010) · Archiv der Pharmazie · doi:10.1002/ardp.200900176 · Cited by 51
Cytotoxic 5-aryl-1-(4-nitrophenyl)-3-oxo-1,4-pentadienes mounted on alicyclic scaffolds
Das, U., Gul, H. I., Alcorn, J., Shrivastav, A., George, T., Sharma, R. K., Nienaber, K. H., Clercq, E. D., Balzarini, J. M., Kawase, M., et al. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.12.014 · Cited by 47
Design and synthesis of quinazolinones as EGFR inhibitors to overcome EGFR resistance obstacle
Patel, H., Pawara, R. H., Ansari, A., Noolvi, M. N., & Surana, S. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.03.039 · Cited by 48
Eldehna, W. M., Salem, R., Elsayed, Z. M., Al-Warhi, T. I., Knany, H. R., Ayyad, R. R. A., Traiki, T. B., Abdulla, M., Ahmad, R., Abdel‐Aziz, H. A., et al. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1944127 · Cited by 47
Hassan, R. A., Emam, S. H., Hwang, D., Kim, G., Hassanin, S. O., Khalil, M. G., Abdou, A. M., & Sonousi, A. S. M. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105487 · Cited by 48
Shchekotikhin, A. E., Shtil, A. A., Luzikov, Y. N., Bobrysheva, T. V., Buyanov, V. N., & PREOBRAZHENSKAYA, M. N. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.12.044 · Cited by 47
Braulio Insuasty, O., Orozco, F., Jairo Quiroga, P., Abonía, R., Nogueras, M., & Cobo, J. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.12.005 · Cited by 47
Kattimani, P. P., Kamble, R. R., Kariduraganavar, M. Y., Dorababu, A., & Hunnur, R. K. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.004 · Cited by 47
Cephalostatins and Ritterazines
Iglesias‐Arteaga, M. A., & Morzycki, J. W. (2013) · The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology · doi:10.1016/b978-0-12-407774-4.00002-9 · Cited by 47
Geodiamolides H and I, further cyclodepsipeptides from the marine sponge Geodia sp
Tinto, W. F., Lough, A. J., McLean, S., Reynolds, W. F., Yu, M. K., & Chan, W. R. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00157-4 · Cited by 53
Wilkinson, B., Gregory, M. A., Moss, S. J., Carletti, I., Sheridan, R., Kaja, A. L., Ward, M., Olano, C., Méndez, C., Salas, J. A., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.073 · Cited by 47
Kaminskyy, D. V., Kryshchyshyn‐Dylevych, A., Nektegayev, I. A., Vasylenko, O., Grellier, P., & Lesyk, R. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.028 · Cited by 46
Fused Thiopyrano[2,3-d]thiazole Derivatives as Potential Anticancer Agents
Kryshchyshyn‐Dylevych, A., Atamanyuk, D., & Lesyk, R. (2012) · Scientia Pharmaceutica · doi:10.3797/scipharm.1204-02 · Cited by 46
Kiselev, E., Sooryakumar, D., Agama, K., Cushman, M., & Pommier, Y. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401471v · Cited by 48
Synthesis and anticancer activity of quinopimaric and maleopimaric acids’ derivatives
Tret’yakova, E. V., Smirnova, I. E., Kazakova, O. B., Tolstikov, G. A., Yavorskaya, N. P., Голубева, И. С., Pugacheva, R. B., Николаевна, А. Г., & Poroikov, V. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.09.030 · Cited by 46
Mahaira, L. G., Tsimplouli, C., Sakellaridis, N., Alevizopoulos, K., Demetzos, C., Han, Z., Pantazis, P., & DIMAS, K. S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.065 · Cited by 46
Cinelli, M. A., Cordero, B., Dexheimer, T. S., Pommier, Y. G., & Cushman, M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.066 · Cited by 46
Antisense DNA-targeting protein kinase A-RIA subunit a novel approach to cancer treatment
Yoon, S. (1999) · Frontiers in bioscience · doi:10.2741/a473 · Cited by 46
de Graaf, H., Mælandsmo, G. M., Ruud, P., Forus, A., Øyjord, T., Fodstad, Ø., & Hovig, E. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<191::aid-ijc27>3.0.co;2-l · Cited by 46
Sonousi, A. S. M., Hassan, R. A., Osman, E. O., Abdou, A. M., & Emam, S. H. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2118735 · Cited by 45
Goel, R., Luxami, V., & Paul, K. (2015) · RSC Advances · doi:10.1039/c5ra00584a · Cited by 45
Reddy, P. V., Jensen, K. C., Mesecar, A. D., Fanwick, P. E., & Cushman, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201251c · Cited by 45
Montoya, A. L., Jairo Quiroga, P., Abonía, R., Nogueras, M., Cobo, J., & Braulio Insuasty, O. (2014) · Molecules · doi:10.3390/molecules191118656 · Cited by 45
Eurtivong, C., Semenov, V. V., Semenova, M. N., Konyushkin, L. D., Atamanenko, O. P., Reynisson, J., & Kiselyov, A. S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.041 · Cited by 45
Santelli‐Rouvier, C., Barret, J.-M. M., Farrell, C. M., Sharples, D., Hill, B. T., & Barbe, J. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.06.015 · Cited by 45
Hu, K., & Yao, X. (2003) · Phytotherapy Research · doi:10.1002/ptr.1211 · Cited by 45
Keskin, Ö., Bahar, I., Jernigan, R. L., Beutler, J. A., Shoemaker, R. H., Sausville, E. A., & Covell, D. G. (2000) · PubMed · Cited by 45
Jonsson, E. W., Fridborg, H., Csóka, K., Dhar, S., Sundström, C., Nygren, P., & Larsson, R. L. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.364 · Cited by 46
Al‐Rashood, S. T., Hassan, G. S., El‐Messery, S. M., Nagi, M. N., Habib, E. E., Al-Omary, F. A. M., & El‐Subbagh, H. I. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.070 · Cited by 44
Singh, I., Rani, R., Luxami, V., & Paul, K. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.053 · Cited by 44
Gabr, M. T., El‐Gohary, N. S., El‐Bendary, E. R., & El‐Kerdawy, M. M. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1114-x · Cited by 46
Dimmock, J. R., Jha, A., Zello, G. A., Quail, J. W., Oloo, E. O., Nienaber, K. H., Kowalczyk, E. S., Allen, T. M., Santos, C. L., Clercq, E. D., et al. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(02)01414-9 · Cited by 44
Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs
Rao, P. N., Cessac, J. W., Tinley, T. L., & Mooberry, S. L. (2002) · Steroids · doi:10.1016/s0039-128x(02)00066-1 · Cited by 44
Heindl, S., Eggenstein, E., Keller, S., Kneißl, J., Keller, G., Mutze, K., Rauser, S., Gasteiger, G., Drexler, I., Hapfelmeier, A., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1128-4 · Cited by 43
Das, U., Sakagami, H., Chu, Q., Wang, Q., Kawase, M., Selvakumar, P., Sharma, R. K., & Dimmock, J. R. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.076 · Cited by 43
The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells
Plitzko, B., Kaweesa, E. N., & Loesgen, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.774836 · Cited by 44
Natural Products as Pharmaceuticals and Sources for Lead Structures
Newman, D. J., Cragg, G. M. L., & Kingston, D. G. I. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374194-3.00008-1 · Cited by 54
Faidallah, H. M., Al‐Saadi, M. S., Rostom, S. A. F., & Fahmy, H. T. Y. (2007) · Medicinal Chemistry Research · doi:10.1007/s00044-007-9033-8 · Cited by 43
Šíša, M., Plá, D., Altuna, M., Francesch, A., Cuevas, C., Alberício, F., & Álvarez, M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900544z · Cited by 43
Ahmad, S., Rathish, I. G., Bano, S., Alam, M. S., & Javed, K. (2009) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903155781 · Cited by 43
Sharma, A., Luxami, V., & Paul, K. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.02.036 · Cited by 44
Molecular Mechanics Force Field for Platinum Coordination Complexes
Cundari, T. R., Fu, W., Moody, E. W., Slavin, L. L., Snyder, L. A., Sommerer, S. O., & Klinckman, T. R. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp961240x · Cited by 43
Khodair, A. I. (2001) · Carbohydrate Research · doi:10.1016/s0008-6215(01)00040-4 · Cited by 43
Non-camptothecin topoisomerase I active compounds as potential anticancer agents
Long, B. H., & Balasubramanian, B. N. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.5.635 · Cited by 43
Bosanquet, A. G., & Bell, P. B. (1996) · Leukemia Research · doi:10.1016/0145-2126(95)00127-1 · Cited by 43
Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer Agents
Ivasechko, I., Yushyn, I., Roszczenko, P., Senkiv, J., Finiuk, N. S., Lesyk, D., Holota, S. M., Czarnomysy, R., Klyuchivska, O., Khyluk, D., et al. (2022) · Molecules · doi:10.3390/molecules27196219 · Cited by 43
Anticancer activities of some newly synthesized pyrazole and pyrimidine derivatives
Mohamed, A. M., El-Sayed, W. A., Alsharari, M. A., Al-Qalawi, H. R. M., & Germoush, M. O. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0163-x · Cited by 42
Design and synthesis of pyrimidine molecules endowed with thiazolidin-4-one as new anticancer agents
Rashid, M., Husain, A., Yar, M. S., Mishra, R., Hussain, A., & Afzal, O. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.033 · Cited by 42
Zahran, S. S., Ragab, F. A.-F., El-Gazzar, M. G., Soliman, A. M., Mahmoud, W. R., & Ghorab, M. M. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114912 · Cited by 42
Bioactive Hydantoin Alkaloids from the Red Sea Marine Sponge Hemimycale arabica
Youssef, D. T. A., Shaala, L. A., & Alshali, K. Z. (2015) · Marine Drugs · doi:10.3390/md13116609 · Cited by 42
Alanazi, A. M., Al-Suwaidan, I. A., Abdel‐Aziz, A. A. ‐., Mohamed, M. A., Morsy, A. M. E., & El‐Azab, A. S. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0546-z · Cited by 42
Hernández‐Folgado, L., Baretić, D., Piantanida, I., Marjanović, M., Kralj, M., Rehm, T. H., & Schmuck, C. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200901999 · Cited by 42
New chemical and biological aspects of artemisinin-Derived trioxane dimers
Posner, G. H., Northrop, J. P., Paik, I., Borstnik, K., Dolan, P., Kensler, T. W., Xie, S., & Shapiro, T. A. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00270-x · Cited by 42
Mendoza, A., Pérez‐Silanes, S., Quiliano, M., Pabón, A., Galiano, S., González, G., Garavito, G., Zimic, M., Vaisberg, A., Aldana, I., et al. (2011) · Experimental Parasitology · doi:10.1016/j.exppara.2011.02.025 · Cited by 42
Verma, M., Luxami, V., & Paul, K. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.07.027 · Cited by 42
Rao, A., Vardhan, M. V. P. S. V., Reddy, N. V. S., Reddy, T. S., Shaik, S. P., Bagul, C., & Kamal, Ä. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.09.002 · Cited by 42
Cushman, M., Mohanakrishnan, A. K., Hollingshead, M. G., & Hamel, E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020218r · Cited by 42
FR901228 causes mitotic arrest but does not alter microtubule polymerization
Sandor, V. A., ROBBINS, A. R., Robey, R. W., Myers, T. G., Sausville, E. A., Bates, S. E., & Sackett, D. L. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200007000-00005 · Cited by 47
Mensah, A. A., Kwee, I., Gaudio, E., Rinaldi, A., Ponzoni, M., Cascione, L., Fossati, G., Stathis, A., Zucca, E., Caprini, G., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3239 · Cited by 41
Atamanyuk, D. V., Zimenkovsky, B. S., & Lesyk, R. (2008) · Journal of Sulfur Chemistry · doi:10.1080/17415990801911723 · Cited by 41
Khdour, O. M., & Skibo, E. B. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b903844b · Cited by 41
Semantic web data warehousing for caGrid
McCusker, J. P., Phillips, J. A., Gonzalez-Beltran, A. N., Finkelstein, A., & Krauthammer, M. O. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-s10-s2 · Cited by 41
Epoxide-containing side chains enhance antiproliferative activity of paullones
Xie, X., Lemcke, T., Gussio, R., Zaharevitz, D. W., Leost, M., Meijer, L., & Kunick, C. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.02.004 · Cited by 41
Rasal, N. K., Sonawane, R., & Jagtap, S. V. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103660 · Cited by 41
Syntheses of novel heterocycles as anticancer agents
Chauhan, P. M. S., Martins, C., & Horwell, D. C. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.02.055 · Cited by 41
11-Oxygenated cytotoxic 8,9-secokauranes from a New Zealand liverwort, Lepidolaena taylorii
Perry, N. B., Burgess, E. J., Baek, S., Weavers, R. T., Geis, W., & Mauger, A. B. (1999) · Phytochemistry · doi:10.1016/s0031-9422(98)00602-5 · Cited by 41
Finkielsztein, L. M., Bruno, A. M., Renou, S. G., & Moltrasio, G. Y. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.10.033 · Cited by 41
New synthetic inhibitors of microtubule depolymerization.
Klar, U., Graf, H., Schenk, O., Röhr, B., & Schulz, H. D. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00226-1 · Cited by 39
Identification and Characterization of a New Tubulin-Binding Tetrasubstituted Brominated Pyrrole
Mooberry, S. L., Weiderhold, K. N., Dakshanamurthy, S., Hamel, E., Banner, E. J., Kharlamova, A., Hempel, J. E., Gupton, J. T., & Brown, M. L. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034876 · Cited by 41
Moscow, J. A., Connolly, T., Myers, T. G., Cheng, C. C., Paull, K. D., & Cowan, K. H. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<184::aid-ijc26>3.0.co;2-i · Cited by 41
Self-citationOrthogonal PLS (OPLS) Modeling for Improved Analysis and Interpretation in Drug Design
Eriksson, L., Rosén, J., Johansson, E., & Trygg, J. (2012) · Molecular Informatics · doi:10.1002/minf.201200158 · Cited by 43
Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines
Kneißl, J., Keller, S., Lorber, T., Heindl, S., Keller, G., Drexler, I., Hapfelmeier, A., Höfler, H., & Luber, B. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1479 · Cited by 41
Kritsanida, M., Magiatis, P., Skaltsounis, A., Peng, Y., Li, P., & Wennogle, L. P. (2009) · Journal of Natural Products · doi:10.1021/np9003905 · Cited by 40
Cytotoxic 1,3-diarylidene-2-tetralones and related compounds
Dimmock, J. R., Padmanilyam, M. P., Zello, G. A., Quail, J. W., Oloo, E. O., Prisciak, J. S., Kraatz, H., Cherkasov, A., Lee, J. S., Allen, T. M., et al. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(02)01402-2 · Cited by 40
Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents
Caputo, R., Calabrò, M. L., Micale, N., Schimmer, A. D., Ali, M. I., Zappalà, M., & Grasso, S. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9789-8 · Cited by 40
Chen, Z., Mocharla, V. P., Farmer, J. M., Pettit, G. R., Hamel, E., & Pinney, K. G. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo0004761 · Cited by 40
Márquez, V. E., Nacro, K., Benzaria, S., Lee, J., Sharma, R., Teng, K., Milne, G. W. A., Bienfait, B., Wang, S., Lewin, N. E., et al. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00048-5 · Cited by 40
Eldehna, W. M., Farès, M., Bonardi, A., Avgenikos, M., Baselious, F., Schmidt, M., Al-Warhi, T. I., Abdel‐Aziz, H. A., Rennert, R. C., Peat, T. S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01894 · Cited by 39
Song, Y., Shao, Z., Dexheimer, T. S., Scher, E. S., Pommier, Y. G., & Cushman, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901649x · Cited by 39
Faidallah, H. M., & Rostom, S. A. F. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.02.006 · Cited by 39
Taher, A. T., & Abou‐Seri, S. M. (2012) · Molecules · doi:10.3390/molecules17089868 · Cited by 39
Synthesis and anti-cancer activity evaluation of new aurone derivatives
Demirayak, Ş., Yurttaş, L., Gündoğdu-Karaburun, N., Karaburun, A. Ç., & Kayağil, İ. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.976568 · Cited by 39
Коваленко, С. І., Antypenko, L., Bilyi, A. K., Kholodnyak, S. V., Karpenko, O. V., Antypenko, O. M., Mykhaylova, N. S., Los, T. I., & Kolomoets, O. S. (2013) · Scientia Pharmaceutica · doi:10.3797/scipharm.1211-08 · Cited by 39
Alanazi, A. M., El‐Azab, A. S., Alswaidan, I. A., Maarouf, A. R., El‐Bendary, E. R., El‐Enin, M. A. A., & Abdel‐Aziz, A. A. ‐. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0597-1 · Cited by 39
Sterically Congested Adamantylnaphthalene Quinone Methides
Veljković, J., Uzelac, L., Molčanov, K., Mlinarić‐Majerski, K., Kralj, M., Wan, P., & Basarić, N. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo3002479 · Cited by 39
Ramírez, J., Svetaz, L. A., Jairo Quiroga, P., Abonía, R., Raimondi, M., Zacchino, S. A., & Braulio Insuasty, O. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.053 · Cited by 38
Kiselev, E., Agama, K., Pommier, Y. G., & Cushman, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201512x · Cited by 38
Finiuk, N. S., Kryshchyshyn‐Dylevych, A., Holota, S. M., Klyuchivska, O., Kozytskiy, A. V., Karpenko, O., Manko, N. O., Ivasechko, I., Стойка, Р. С., & Lesyk, R. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114422 · Cited by 39
Ivasechko, I., Lozynskyi, A., Senkiv, J., Roszczenko, P., Kozak, Y., Finiuk, N. S., Klyuchivska, O., Kashchak, N., Manko, N. O., Maslyak, Z., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115304 · Cited by 38
Souza, B. J., Oliveira, T. D., de Aquino, T. M., de Lima, M. C. P., Pitta, I. D. R., Galdino, S. L., Lima, E. D. O., Gonçalves-Silva, T., Militão, G. C. G., Scotti, L., et al. (2012) · Acta Pharmaceutica · doi:10.2478/v10007-012-0017-y · Cited by 38
In vitro modelling of human tumour behaviour in drug discovery programmes
Baguley, B. C., & Marshall, E. S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.019 · Cited by 38
Isoindolo[2,1-c]benzo[1,2,4]triazines: A new ring system with antiproliferative activity
Diana, P., Martorana, A., Barraja, P., Lauria, A., Montalbano, A., Almerico, A. M., Dattolo, G., & Cirrincione, G. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.054 · Cited by 38
Abdou, W. M., Khidre, R. E., & Kamel, A. A. (2011) · Archiv der Pharmazie · doi:10.1002/ardp.201100080 · Cited by 38
Ranise, A., Spallarossa, A., Bruno, O., Schenone, S., Fossa, P., Menozzi, G., Bondavalli, F., Mosti, L., Capuano, A., Mazzeo, F., et al. (2003) · Il Farmaco · doi:10.1016/s0014-827x(03)00132-0 · Cited by 38
Noolvi, M. N., & Patel, H. (2011) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2010.12.031 · Cited by 40
Zhang, A., & Lin, G. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00158-x · Cited by 38
Güzel-Akdemir, Ö., & Salman, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.07.065 · Cited by 38
Singh, A., & Thakur, N. L. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.009 · Cited by 38
Aydın, S. (2013) · MARMARA PHARMACEUTCAL JOURNAL · doi:10.12991/201317389 · Cited by 37
Metadata
- Authors
- Boyd, M. R., & Paull, K. D.
- Affiliations
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Corresponding author
- Boyd, Michael R.
- ORCID
- Boyd, Michael R.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 34
- Issue
- 2
- Pages
- 91-109
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W2118909720
- Cited by
- 1,572
- References
- 40
- Citations by year
- 2026: 28 · 2025: 57 · 2024: 79 · 2023: 58 · 2022: 68 · 2021: 81 · 2020: 74 · 2019: 51 · 2018: 58 · 2017: 39 · 2016: 56 · 2015: 61 · 2014: 78 · 2013: 84 · 2012: 79
- FWCI
- 30.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Development Research (publishedVersion, public-domain)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- anticancer drug discovery, human cancer cell lines, anticancer activity, lead compound identification, mechanism of action
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.